Ledger.Open graph →
SEC Form D · Amendment · filed May 12, 2017

CHD Bioscience, Inc

Offering
$14.0M
Sold
$2.7M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
FORT COLLINS, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Robert Kali · Fort Collins, COExecMichael Handley · Fort Collins, COExec · DirectorDennis Templar · Fort Collins, COExec · DirectorWilliam Nelson · Fort Collins, CODirectorAlan Smith · Fort Collins, CODirectorTed Ziemann · Fort Collins, COExec · DirectorAlan Ruud · Fort Collins, CODirectorMichael Litwack · Fort Collins, CODirectorStephen Coder · Fort Collins, CODirectorEd Neas · Fort Collins, COExec · DirectorPeter E. Mogk · DETROIT, MIExec · DirectorRohan N. Oza · New York, NYDirectorTimothy W. Reick · New York, NYDirectorAnanth Pradeep · El Cerrito, CAExec · DirectorDominick Maggio · New York, NYExecDev Equity Partners II, LLC · Tucson, AZDirectorJohn Anderson · Vancouver, British Columbia, CanadaDirectorCameron Gray · CAMBRIDGE, MAExec · DirectorMatthew Chick · St. Peter Port, Y7DirectorDavid B. Thompson · Pittsburgh, PAExec · DirectorDavid Depaolo · New York, NYDirectorAnthony Digiandomenico · CAMBRIDGE, MAExec · DirectorStephen L. Scott · San Diego, CAExecDaniel Passeri · CAMBRIDGE, MAExec · DirectorDon T. Ebanks · Grand Cayman, Cayman IslandsExec · DirectorClayton N. Christopher · New York, NYExec · DirectorGang Lu · Laguna Hills, CADirectorCale Thomas · Vancouver, British Columbia, CanadaDirectorMaiden Lane Spin-Off Advisors, LLC · New York, NYDirectorThomas Deutsch · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗